- Home
- AZTA
AZTA
Azenta Inc.
as 02-21-2025 4:00pm EST
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
| Founded: | 1978 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 2.4B | IPO Year: | 1995 |
| Target Price: | $58.75 | AVG Volume (30 days): | 548.4K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $38.82 - $67.77 | Next Earning Date: | 02-05-2025 |
| Revenue: | $662,108,000 | Revenue Growth: | 5.36% |
| Revenue Growth (this year): | -7.41% | Revenue Growth (next year): | 6.29% |
Stock Insider Trading Activity of Azenta Inc. (AZTA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hughes Violetta | AZTA | VP, Chief Accounting Officer | Feb 3 '25 | Sell | $52.97 | 317 | $16,791.49 | 9,603 | |
| Zhou Ginger | AZTA | SVP and General Manager, Genom | Jan 31 '25 | Buy | $45.88 | 417 | $19,131.96 | 27,916 |
Latest Azenta Inc. News
AZTA Breaking Stock News: Dive into AZTA Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
AZTA: Lowering target price to $36.00
StockStory
17 days ago
Azenta’s (NASDAQ:AZTA) Q4 Sales Top Estimates
PR Newswire
17 days ago
Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024
Argus Research
18 days ago
AZTA: Lowering target price to $42.00
Insider Monkey
18 days ago
Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently?
PR Newswire
23 days ago
Azenta Announces the Election of Dipal Doshi to its Board of Directors
Argus Research
25 days ago
AZTA: What does Argus have to say about AZTA?
PR Newswire
a month ago
Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast
Compare AZTA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AZTA Azenta Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.